Murcia, Spain

Christian Rocaboy

This inventor holds 4 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2018-2021.

USPTO Granted Patents = 4 

% Patents Active = 50.0

 

 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2018-2021

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Christian Rocaboy

Introduction

Christian Rocaboy is a notable inventor based in Murcia, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target androgen receptors. With a total of four patents to his name, Rocaboy's work is paving the way for new treatments in various medical disorders.

Latest Patents

Among his latest patents, Rocaboy has developed substituted thiohydantoin derivatives as androgen receptor antagonists. These patents disclose compounds, compositions, and methods for treating disorders that are affected by the antagonism of one or more androgen receptor types. The compounds are represented by specific formulas, which detail the structural components necessary for their efficacy.

Career Highlights

Christian Rocaboy is currently employed at Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His work at Janssen has allowed him to focus on innovative solutions that address critical health issues. Rocaboy's expertise in pharmacology and his dedication to research have made him a valuable asset to his team.

Collaborations

Rocaboy has collaborated with esteemed colleagues such as Peter J Connolly and Gilles C Bignan. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical products.

Conclusion

Christian Rocaboy's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to inspire future developments in the treatment of disorders related to androgen receptors.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…